childhood myopia

Myopia, Dopavision
Germany's Dopavision closes €12M Series A round for digital childhood myopia treatment
By Sara Mageit | 07:55 am | July 15, 2021
The proceeds will be used to fund the clinical development of MyopiaX, the company's lead product in childhood myopia.